Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Non-Current Liabilities: 2022-2023

Historic Other Non-Current Liabilities for Immunocore Holdings (IMCR) over the last 2 years, with Dec 2023 value amounting to $978,000.

  • Immunocore Holdings' Other Non-Current Liabilities rose 3113.71% to $96.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.6 million, marking a year-over-year increase of 3113.71%. This contributed to the annual value of $978,000 for FY2023, which is 55.85% down from last year.
  • As of FY2023, Immunocore Holdings' Other Non-Current Liabilities stood at $978,000, which was down 55.85% from $2.2 million recorded in FY2022.
  • Immunocore Holdings' 5-year Other Non-Current Liabilities high stood at $2.2 million for FY2022, and its period low was $978,000 during FY2023.
  • Its 2-year average for Other Non-Current Liabilities is $1.6 million, with a median of $1.6 million in 2022.
  • Data for Immunocore Holdings' Other Non-Current Liabilities shows a maximum YoY slumped of 55.85% (in 2023) over the last 5 years.
  • Immunocore Holdings' Other Non-Current Liabilities (Yearly) stood at $2.2 million in 2022, then slumped by 55.85% to $978,000 in 2023.